Home › Funds › Boxer Capital Management, LLC › QTTB
Boxer Capital Management, LLC position in QTTB
Q32 Bio Inc · Health Care
Boxer Capital Management, LLC reported holding 3,149,310 shares of QTTB (Q32 Bio Inc) in its Q2 2026 13F filing — a position valued at US$40.1M, representing 3.02% of its reported portfolio and ranking #10 among its reported holdings. Boxer Capital Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's QTTB position evolved
Boxer Capital Management, LLC first disclosed a stake in QTTB in Q2 2026 at 3,149,310 shares (US$40.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 3.15M | $40.12M | New |
About QTTB and 13F data
QTTB (Q32 Bio Inc) is a Health Care company. 50 other funds we track also report a position in QTTB — the largest reported positions include ORBIMED ADVISORS LLC (US$52.6M), Atlas Venture Life Science Advisors, LLC (US$34.6M), BVF INC/IL (US$29.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding QTTB
- ORBIMED ADVISORS LLC 4.13M sh · $52.59M · Q2 2026
- Atlas Venture Life Science Advisors, LLC 2.72M sh · $34.62M · Q2 2026
- BVF INC/IL 2.35M sh · $29.94M · Q2 2026
- Opaleye Management Inc. 931.00K sh · $11.86M · Q2 2026
- Logos Global Management LP 800.00K sh · $10.19M · Q2 2026
- Sanofi 244.08K sh · $3.11M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 216.17K sh · $2.75M · Q2 2026
- Carlyle Group Inc. 60.36K sh · $769.02K · Q2 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held QTTB?
Boxer Capital Management, LLC has disclosed QTTB holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Boxer Capital Management, LLC's current position in QTTB?
As of Q2 2026, Boxer Capital Management, LLC holds 3.15M shares of QTTB (Q32 Bio Inc), valued at $40.12M, representing 3.02% of its reported portfolio and ranking #10.
Has Boxer Capital Management, LLC been buying or selling QTTB?
In the latest 13F filing (Q2 2026), Boxer Capital Management, LLC newly opened its position in QTTB.
Which other funds hold QTTB?
Other major institutional holders of QTTB include ORBIMED ADVISORS LLC, Atlas Venture Life Science Advisors, LLC, BVF INC/IL, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.